Cargando…
Fabry disease, respiratory symptoms, and airway limitation – a systematic review
BACKGROUND: Fabry disease is an X-linked disorder caused by a deficiency of the lysosomal enzyme α-galactosidase A, resulting in accumulation of glycosphingolipids in multiple organs, primarily heart, kidneys, skin, CNS, and lungs. MATERIALS AND METHOD: A systematic literature search was performed u...
Autores principales: | Svensson, Camilla Kara, Feldt-Rasmussen, Ulla, Backer, Vibeke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629719/ https://www.ncbi.nlm.nih.gov/pubmed/26557248 http://dx.doi.org/10.3402/ecrj.v2.26721 |
Ejemplares similares
-
Fabry Disease and Early Stroke
por: Feldt-Rasmussen, U.
Publicado: (2011) -
Systematic cascade screening in the Danish Fabry Disease Centre: 20 years of a national single-centre experience
por: Effraimidis, Grigoris, et al.
Publicado: (2022) -
Correction: Systematic cascade screening in the Danish Fabry Disease Centre: 20 years of a national single-centre experience
por: Effraimidis, Grigoris, et al.
Publicado: (2023) -
Improvement of gastrointestinal symptoms in a significant proportion of male patients with classic Fabry disease treated with agalsidase beta: A Fabry Registry analysis stratified by phenotype
por: Hopkin, Robert J., et al.
Publicado: (2020) -
Hearing loss in fabry disease: A 16 year follow-up study of the Danish
nationwide cohort
por: Yazdanfard, Puriya Daniel Würtz, et al.
Publicado: (2022)